[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100654398":3},{"organization":4,"outcomesModule":7,"designInfo":14,"detailedDescription":17,"studyPopulation":18,"armGroups":19,"interventions":25,"overallOfficials":13,"centralContacts":31,"locations":41,"responsibleParty":56,"collaborators":58,"id":62,"slug":63,"hasResults":64,"nctId":65,"briefTitle":66,"officialTitle":67,"acronym":68,"eligibilityCriteria":69,"healthyVolunteers":64,"sex":70,"minAge":71,"maxAge":13,"enrollmentInfo":72,"targetDuration":75,"studyType":76,"phases":13,"briefSummary":77,"conditions":78,"keywords":80,"overallStatus":44,"whyStopped":13,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"SoLa Pelvic Therapy","INDUSTRY",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":13},[9],{"measure":10,"description":11,"timeFrame":12},"Change in Chronic Pelvic Pain Severity","Change in patient-reported pelvic pain severity following SoLá Pelvic Therapy (SPT), assessed using the Numeric Pain Rating Scale (NPRS), ranging from 0 (no pain) to 10 (worst possible pain). Lower scores indicate less pain.","Baseline through 12 months",null,{"allocation":13,"interventionModel":13,"interventionModelDescription":13,"primaryPurpose":13,"observationalModel":15,"timePerspective":16,"maskingInfo":13},"COHORT","PROSPECTIVE","The VOICE Registry is a prospective, multicenter, observational registry designed to evaluate the real-world use of transvaginal photobiomodulation with SoLá Pelvic Therapy® in patients with chronic pelvic pain. Participants receive SoLá Pelvic Therapy® as part of their standard clinical care, independently of participation in the registry.\n\nThe registry does not assign treatment or dictate clinical management. Decisions regarding patient selection, treatment frequency, treatment regimen, and concomitant therapies remain at the discretion of the treating healthcare professional. Participants are followed for 12 months from initiation of therapy to collect longitudinal information on device utilization, safety, and patient-reported outcomes.","Adults aged 18 years or older who are selected by their treating healthcare professional to receive transvaginal photobiomodulation with SoLá Pelvic Therapy® as part of standard clinical care. Participants are enrolled from routine clinical practice at participating healthcare sites.",[20],{"label":21,"type":13,"description":22,"interventionNames":23},"Patients Receiving SoLá Pelvic Therapy","Patients with chronic pelvic pain receiving SoLá Pelvic Therapy (SPT) as part of routine clinical care. Participants are followed prospectively through the registry to collect treatment, use and safety information.",[24],"Device: SoLá Pelvic Therapy (SPT)",[26],{"type":27,"name":28,"description":29,"armGroupLabels":30,"otherNames":13},"DEVICE","SoLá Pelvic Therapy (SPT)","SoLá Pelvic Therapy (SPT) is administered as part of routine clinical care to patients with chronic pelvic pain. Treatment is not assigned by the registry. The registry prospectively collects treatment, and safety information from patients receiving SPT at participating sites.",[21],[32,37],{"name":33,"role":34,"phone":35,"phoneExt":13,"email":36},"Georgine Lamvu, MD, MPH","CONTACT","407-461-1189","georgine@solapelvictherapy.com",{"name":38,"role":34,"phone":39,"phoneExt":13,"email":40},"Pilar Garcia, MD","561-850-1629","pilar@solapelvictherapy.com",[42],{"facility":43,"status":44,"city":45,"state":46,"zip":47,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":13},"Zipper Urogynecology Associates","RECRUITING","Melbourne","Florida","32901","United States","US",{"type":51,"coordinates":52},"Point",[53,54],-80.60811,28.08363,{"lat":54,"lon":53},{"type":57,"investigatorFullName":13,"investigatorTitle":13,"investigatorAffiliation":13,"oldNameTitle":13,"oldOrganization":13},"SPONSOR",[59],{"name":60,"class":61},"Uroshape LLC","UNKNOWN","100654398","a-prospective-registry-of-vaginal-photobiomodulation-for-chronic-pelvic-pain-100654398",false,"NCT07799857","A Prospective Registry of Vaginal Photobiomodulation for Chronic Pelvic Pain.","A Prospective Registry of Vaginal Photobiomodulation for Chronic Pelvic Pain: The VOICE Registry.","VOICE Registry","Inclusion Criteria:\n\n* Age 18 years or older.\n* Selected to receive transvaginal photobiomodulation therapy with the SoLá Pelvic Therapy® as part of their standard clinical care.\n\nExclusion Criteria:\n\n\\- Patients will be excluded from the registry only if the treating healthcare professional determines that SoLá Pelvic Therapy® is not appropriate or contraindicated.","FEMALE","18 Years",{"count":73,"type":74},1000,"ESTIMATED","12 Months","OBSERVATIONAL","The VOICE Registry is a multicenter, prospective, observational registry designed to collect real-world data on the clinical use of SoLá Pelvic Therapy® (SPT) in patients with chronic pelvic pain (CPP). The registry will follow patients receiving transvaginal photobiomodulation (PBM) therapy with SPT as part of their standard clinical care. The primary purpose of the registry is to collect real-world evidence on the use and safety of SPT.",[79],"Chronic Pelvic Pain",[79,81,82,83,84,85],"Pelvic Pain","Photobiomodulation","Transvaginal Photobiomodulation","SoLá Pelvic Therapy","Pelvic Floor Dysfunction","2026-09-01",{"date":88,"type":89},"2026-09-02","ACTUAL",{"date":91,"type":89},"2026-04-06",{"date":93,"type":74},"2030-04",{"name":5,"class":6},1]